When "compliance" no longer equals "safety," the hygiene products industry is undergoing a deep shift from a bottom-line mindset to risk-forward thinking. At a closed-door symposium held in early September in Changxing, Huzhou, Zhejiang, experts from pharmaceutical GMP, food safety, medical devices, cosmetics, pest control, and third-party testing sat together to map a cross-industry "safety coordinate system" for hygiene and maternal-infant products, focusing on physical, chemical, and biological risk dimensions.
Event Background
The symposium, organized by the Hygiene and Maternal-Infant Products Branch of China Nonwovens & Industrial Textiles Association, centered on risk tracing and cross-industry regulatory benchmarking. By bringing together standard-setters from highly regulated sectors like pharmaceuticals, food, and medical devices, the industry signaled its proactive move toward higher safety benchmarks. The concept proposed by a R&D leader from Jinsan Group—"using consumer safety as the endpoint to reverse-engineer product design"—essentially shifts safety standards from the production end to the raw material and R&D stages, establishing a three-dimensional traceability matrix of "risk type × product scenario × global regulations."
This shift is directly linked to frequent safety incidents in maternal-infant products and declining consumer trust. The old practice of "meeting national standards is enough to go to market" can no longer cope with rapidly amplified public opinion risks on e-commerce platforms. A reminder from an East China University of Political Science and Law expert is worth pondering: product compliance does not equal public opinion safety; risks do not stop at the factory gate, and perceptibility determines explosive power. This means companies must manage not only foreign matter and microorganisms on the production line but also negative reviews on consumers' phone screens.
Industry Impact
From a technical implementation perspective, the signals released at the meeting will have substantial impacts on both upstream and downstream supply chains. In the physical risk dimension, experts proposed a five-line defense for foreign matter control—source prevention, process leak prevention, online detection, reliable rejection, and trend warning with event tracing. While not entirely new, systematizing these into a full closed-loop means equipment suppliers like metal detectors and X-ray machines will see clearer procurement demand. For small and medium factories, this system may bring incremental costs for equipment upgrades and personnel training, but in the long run, it is a necessary investment to avoid mass recalls and brand collapse.
Chemical risk control is complicated by supply chain complexity. An engineer from Hangzhou Daddy Evaluation pointed out that risk substances come not only from direct raw material suppliers but may also be hidden in indirect suppliers and product risk manufacturers. This requires companies to shift from single-point testing to multi-layer monitoring, and from targeted detection to non-targeted screening. For purchasers, this means supplier audit standards will rise significantly; a single test report is no longer sufficient. In the biological risk dimension, microbial control is detailed into a full lifecycle of six lines of defense, from R&D design, water systems, to packaging and storage. Pest management is explicitly defined as a systemic risk, not a simple cleaning issue.
Notably, the meeting emphasized "global regulatory benchmarking." In the hygiene products field, where exports account for a large share, differences in risk substance limits across markets are huge. Companies focusing only on domestic standards may easily encounter barriers in high-end markets like Europe, the US, and Japan. Building a global regulatory database is essentially a public infrastructure to reduce export compliance costs. For small and medium enterprises reliant on foreign trade, this may be a more efficient path than studying overseas regulations alone.
Practical Recommendations
Another highlight of the symposium was the expert co-creation workshop model. Unlike typical industry conferences with "speaking on stage, listening below," experts from different fields were divided into groups to discuss three-dimensional risks deeply and collectively sort out regulations from China, the US, the EU, and Japan across pharmaceuticals, food, medical devices, cosmetics, and toys. This cross-industry co-creation is being transformed into a continually updated industry asset. A professor from Tiangong University made a thought-provoking point in his summary: the core of risk governance is not to prove that we have never had problems, but to establish a mechanism that can detect early, locate quickly, handle scientifically, and improve continuously.